➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Moodys
Baxter
Boehringer Ingelheim
Mallinckrodt

Last Updated: April 11, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ERIBULIN MESYLATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

ERIBULIN MESYLATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai Inc HALAVEN eribulin mesylate SOLUTION;INTRAVENOUS 201532 NDA BSP Pharmaceuticals SpA 43624-002-01 100 TRAY in 1 BOX, UNIT-DOSE (43624-002-01) > 3 mL in 1 TRAY
Eisai Inc HALAVEN eribulin mesylate SOLUTION;INTRAVENOUS 201532 NDA Eisai Inc. 62856-389-01 1 VIAL in 1 CARTON (62856-389-01) > 2 mL in 1 VIAL
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Medtronic
Johnson and Johnson
McKinsey
Baxter